Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
3.620
+0.900 (33.09%)
Apr 13, 2026, 11:09 AM EDT - Market open
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $882.48 million as of April 13, 2026. Its market cap has increased by 158.71% in one year.
Market Cap
882.48M
Enterprise Value
496.12M
1-Year Change
158.71%
Ranking
Category
Stock Price
$3.62
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $882.48M, a decrease of -69.37%. That is a compound annual growth rate of -14.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 663.08M | 115.37% |
| Dec 31, 2025 | 307.88M | -31.06% |
| Dec 31, 2024 | 446.60M | -17.32% |
| Dec 29, 2023 | 540.17M | -40.45% |
| Dec 30, 2022 | 907.08M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 727.72M |
| Tenax Therapeutics | 725.58M |
| SpyGlass Pharma | 693.60M |
| Arvinas | 692.06M |
| Gyre Therapeutics | 674.81M |
| BridgeBio Oncology Therapeutics | 672.28M |
| Forte Biosciences | 658.58M |
| Alpha Tau Medical | 641.59M |